Clicky

Incorporating Esketamine into Practice for Treatment-Resistant Depression

Evolving Management Strategies for Treatment-Resistant Depression – Episode 11

May 27, 2021

,

Angelos Halaris, MD, PhD, APA, ACNP, CINP

,

,

Patricia Ares-Romero, MD, FASAM

Additional variables that require consideration if treating appropriate patients with treatment-resistant depression with intranasal esketamine within certified treatment facilities.